Skip to main content

Advertisement

Log in

Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

The aim of the study was to explore the relationship between Swedish drug sales data per municipality and morbidity per municipality. The morbidity was expressed as “sickness numbers” which are assumed to function as proxy for morbidity.

Methods

Sickness numbers per municipality were correlated to volumes of drug sales per municipality in 2003. In addition, the sales volumes of antibiotics were correlated to the sales volumes of other drugs.

Results

We found significant positive correlations between municipality sickness numbers and sales volumes for most drug groups, except for antibiotics where the correlations were negative in all age groups. When the volumes of antibiotics were related to the volumes of other drug groups it was observed that municipalities with volumes of antibiotics above the national average had reduced volumes of cardiovascular drugs, especially of diuretics, beta blockers and calcium antagonists, all primarily used as antihypertensives. For ACE inhibitors and statins, no such relationship was found.

Conclusion

The findings might suggest a link between infection and hypertension, but a cause-effect relation is not established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Capella D (1993) Drug utilization studies: methods and uses. In: Dukes MNG (ed) WHO regional publication. European series; no 45:55–78

  2. Carstairs V (1995) Deprivation indices: their interpretation and use in relation to health. J Epidemiol Municipal Health 2:S3–S8, Suppl

    Article  Google Scholar 

  3. Vegni FE, Wilkinson P (2004) Metodological issues in using drugs data in epidemiology. Ann Ig 16:479–485

    PubMed  CAS  Google Scholar 

  4. Vegni FE, Wilkinson P (2004) The role of drug use data in public health research. Ann Ig 16:487–495

    PubMed  CAS  Google Scholar 

  5. Melander A, Nilsson E, Nilsson L, Liedholm H, Lindahl S-O, Lindblad U (1999) Unnecessary expensive drugs for treatment of hypertension (in Swedish) NEPI Report, Apotekarsocieteten, Stockholm

  6. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430–436

    Article  PubMed  CAS  Google Scholar 

  7. Brassard P, Bourgault C, Brophy J, Kezouh A, Rainville B, Xhignesse M, Suissa S (2003) Antibiotics in the primary prevention of myocardial infarction among elderly patients with hypertension. Am Heart J 145:E20

    Article  PubMed  CAS  Google Scholar 

  8. O’Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD ( 2003) Azithromycin for the secondary prevention of coronary heart disease events. JAMA 290:1459–1466

    Article  PubMed  CAS  Google Scholar 

  9. Danesh J (2005) Antibiotics in the prevention of heart attacks. Lancet 365:365–367

    PubMed  Google Scholar 

  10. Wells BJ, Mainous AG III, Dickerson LM (2004) Antibiotics for the secondary prevention of ischemic heart disease. Arch Intern Med 164:2156–2161

    Article  PubMed  Google Scholar 

  11. Brassard P, Bourgault C, Brophy J, Kezouh A, Suissa S (2003) Antibiotics in primary prevention of stroke in the elderly. Stroke 34:e163–e167

    Article  PubMed  CAS  Google Scholar 

  12. Angeli F, Verdeccia P, Pellegrino C et al (2003) Association between peridontal disease and left ventricle mass in hypertension. Hypertension 41:488–492

    Article  PubMed  CAS  Google Scholar 

  13. Hemmingsson T, Lundberg I (2005) How far are socioeconomic differences in coronary heart disease hospitalization, all-cause mortality and cardiovascular mortality among adult Swedish males attributable to negative childhood circumstances and behaviour in adolescence? Int J Epidemiol 34:260–267

    Article  PubMed  Google Scholar 

  14. Henricson K, Stenberg P, Rametsteiner G, Ranstam J, Hanson BS, Melander A (1998) Socioeconomic factors, morbidity and drug utilization-an ecological study. Pharmacoepidemiol Drug Saf 7:261–267

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We wish to thank the Swedish Social Insurance Administration for supplying us with the sickness numbers. The studies performed comply with the Swedish legislation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Lars G. Nilsson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilsson, J.L.G., Lindberg, G., Johansson, H. et al. Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives. Eur J Clin Pharmacol 62, 675–680 (2006). https://doi.org/10.1007/s00228-006-0157-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-006-0157-4

Keywords

Navigation